"Centre hospitalier régional - public toutes spécialités médicales et chirurgicales 24H/24 Urgences et SAMU - consultations - imagerie - laboratoires."

During the past decade, CHR d'ORLEANS conducted 226 clinical trials. In the 10-year time frame, 226 clinical trials started and 24 clinical trials were completed, i.e. on average, 10.6% percent of trials that started reached the finish line to date. In the past 5 years, 109 clinical trials started and 21 clinical trials were completed. i.e. 19.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHR d'ORLEANS" #1 sponsor was "Centre Hospitalier Régional d'Orléans" with 70 trials, followed by "UNICANCER" with 20 trials sponsored, "ARCAGY/ GINECO GROUP" with 19 trials sponsored, "Intergroupe Francophone de Cancerologie Thoracique" with 15 trials sponsored and "Federation Francophone de Cancerologie Digestive" with 15 trials sponsored. Other sponsors include 198 different institutions and companies that sponsored additional 109 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHR d'ORLEANS" #1 collaborator was "Ministry of Health, France" with 10 trials as a collaborator, "University Hospital, Tours" with 9 trials as a collaborator, "Bristol-Myers Squibb" with 5 trials as a collaborator, "AstraZeneca" with 4 trials as a collaborator and "European Organisation for Research and Treatment of Cancer - EORTC" with 4 trials as a collaborator. Other collaborators include 228 different institutions and companies that were collaborators in the rest 193 trials.

According to Clinical.Site data, the most researched conditions in "CHR d'ORLEANS" are "Rheumatoid Arthritis" (13 trials), "COVID-19" (9 trials), "Colorectal Cancer" (8 trials), "Ovarian Cancer" (8 trials) and "Multiple Myeloma" (6 trials). Many other conditions were trialed in "CHR d'ORLEANS" in a lesser frequency.

Most popular intervention types in "CHR d'ORLEANS" are "Drug" (170 trials), "Other" (83 trials), "Procedure" (37 trials), "Device" (29 trials) and "Biological" (22 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (27 trials), "fluorouracil" (11 trials), "leucovorin calcium" (9 trials), "radiation therapy" (8 trials) and "gemcitabine hydrochloride" (7 trials). Other intervention names were less common.

The vast majority of trials in "CHR d'ORLEANS" are 296 trials for "All" genders, 33 trials for "Female" genders and 12 trials for "Male" genders.

Currently, there are NaN active trials in "CHR d'ORLEANS". 7 are not yet recruiting, 63 are recruiting, 25 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 196 completed trials in CHR d'ORLEANS, 1 suspended trials, and 30 terminated clinical trials to date.

Out of the total trials that were conducted in CHR d'ORLEANS, 6 "Phase 1" clinical trials were conducted, 71 "Phase 2" clinical trials and 97 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 87 trials that are defined as “Not Applicable".

CHR d'ORLEANS has several departments that took part in Clinical trials: "CHR ORLEANS - Hématologie" - 6 trials, "HOPITAL DE LA SOURCE; Service de Cardiologie, Point Jaune" - 2 trials, "Hopital de La Source; Service de Nephrologie & Hemodialyse" - 2 trials